In the meantime, I came across this news from Amyris stating that the company has terminated its toll manufacturing deal with Tate & Lyle Ingredients Americas, which started in 2010. The toll manufacturing agreement entails secured manufacturing capacity for farnesene through 2016 at Tate & Lyle's Decatur, Illinois, facility. The deal included a base monthly payment regardless of level production of Tate & Lyle's facility in addition to a variable amount based on volume.
![]() |
| Tate & Lyle's Decatur, Illinois, facility |

No comments:
Post a Comment